# A Study of Roxadustat for the Treatment of Anemia in Participants With Chronic Kidney Disease and Not Receiving Dialysis

> **NCT01750190** · PHASE3 · COMPLETED · sponsor: **Kyntra Bio** · enrollment: 922 (actual)

## Conditions studied

- CKD Anemia

## Interventions

- **DRUG:** Roxadustat
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01750190
- **Lead sponsor:** Kyntra Bio
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11-05
- **Primary completion:** 2018-09-24
- **Final completion:** 2018-09-24
- **Target enrollment:** 922 (ACTUAL)
- **Last updated:** 2021-10-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01750190

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01750190, "A Study of Roxadustat for the Treatment of Anemia in Participants With Chronic Kidney Disease and Not Receiving Dialysis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01750190. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*